Integrating network analysis and machine learning to explore the pharmacological targets and associations of oleanolic acid in lung adenocarcinoma
Ying Zeng, Hongting Jiang, Fei Zhang, Cha Luo, Zhonglian Wang, Zhiming Ren, Zhihao Xu, Wen Li, Qing Ye, Wei Jian, Jing Zhang, Qiaofen Fu · 2026
Read Integrating network analysis and machine learning to explore the pharmacological targets and associations of oleanolic acid in lung adenocarcinoma by Ying Zeng, Hongting Jiang, Fei Zhang, Cha Luo, Zhonglian Wang, Zhiming Ren, Zhihao Xu, Wen Li, Qing Ye, Wei Jian, Jing Zhang, Qiaofen Fu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13630726.txt.
Description
Ying Zeng and co-authors join in 2026 network study and machine learning to find drug targets of a plant compound in lung adenocarcinoma. The cancer type kills at high rates, and the compound shows anti-tumor hints with unclear paths. Public databases supply the first gene pool for the hunt.
Twenty one candidate genes narrow to two key markers by learning methods. One marker runs high in tumors while the other runs low, each tied to outlook. Docking math gauges how the compound grips those markers. Animal tests and clinic samples give a first check of the lab claims.
Catalog record
| CREATOR | Ying Zeng, Hongting Jiang, Fei Zhang, Cha Luo, Zhonglian Wang, Zhiming Ren, Zhihao Xu, Wen Li, Qing Ye, Wei Jian, Jing Zhang, Qiaofen Fu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |